When I graduated from the University of Pennsylvania School of Medicine in 2008, there was no SARS Cov-2 virus. We still treated hepatitis C with pegylated interferon and ribavirin. We didn’t have the glp-1 agonists like dulaglutide to treat diabetes, or continuous glucose monitoring devices. Medicine is constantly changing, and clinicians struggle to stay up-to-dateContinue reading “Continuing Medical Education”